Physician profile
Jonathan White
NPI 1205283686
$1,208.09
in general payments reported to CMS, 2019-2025
15 companies · $432 in 2025
The $432 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $93.02 · 2022: $205 · 2023: $215 · 2024: $263 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $909.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $225.40 | 2023-2024 | Viaflow, Augment Injectable, Easyfuse |
| Legacy Ortho LLC | $149.10 | 2025 | |
| Averitas Pharma INC. | $122.73 | 2025 | Qutenza |
| Paratek Pharmaceuticals, INC. | $106.09 | 2024-2025 | Nuzyra |
| Organogenesis INC. | $103.81 | 2024 | |
| Bioventus LLC | $103.59 | 2025 | Exogen Ultrasound Bone Healing System |
| Medtronic, INC. | $98.90 | 2023 | Intellis Adaptivestim |
| Smith+Nephew, INC. | $68.25 | 2021-2022 | |
| Cdc Medical LLC | $63.98 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $42.58 | 2022 | |
| Nabriva Therapeutics, Plc | $39.43 | 2021-2022 | |
| Nevro Corp. | $28.36 | 2022 | |
| Heron Therapeutics, INC. | $25.27 | 2021 | |
| Horizon Therapeutics Plc | $16.69 | 2022 | |
| Alfasigma USA, INC. | $13.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.